North Carolina biotechnology company Precision BioSciences is splitting into two divisions, one that will focus on humans and another that will focus on plant biotechnology. With the change, the Durham company is creating Precision PlantSciences, a subsidiary that will focus on developing the company’s technology for agricultural applications. Precision BioSciences will continue its genomics research […]
Last month, my colleague Shane Climie wrote a post inspired by an article in the New York Times (“How Bright Promise in Cancer Testing Fell Apart”), which exposed disturbing and cautionary insights into the application of genetic testing technology. Today, I’m responding to a recent New York Times article in which reporter Andrew Pollack wrote […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.